BR112023003093A2 - Novos derivados de isobutiramida, preparações cosméticas e/ou dermatológicas contendo tais compostos, assim como seu uso para a profilaxia contra e tratamento de pele sensível, em particular, inflamada ou de condições in-flamatórios da pele - Google Patents
Novos derivados de isobutiramida, preparações cosméticas e/ou dermatológicas contendo tais compostos, assim como seu uso para a profilaxia contra e tratamento de pele sensível, em particular, inflamada ou de condições in-flamatórios da peleInfo
- Publication number
- BR112023003093A2 BR112023003093A2 BR112023003093A BR112023003093A BR112023003093A2 BR 112023003093 A2 BR112023003093 A2 BR 112023003093A2 BR 112023003093 A BR112023003093 A BR 112023003093A BR 112023003093 A BR112023003093 A BR 112023003093A BR 112023003093 A2 BR112023003093 A2 BR 112023003093A2
- Authority
- BR
- Brazil
- Prior art keywords
- new
- isobutyramide
- inflamed
- cosmetic
- derivatives
- Prior art date
Links
- WFKAJVHLWXSISD-UHFFFAOYSA-N isobutyramide Chemical class CC(C)C(N)=O WFKAJVHLWXSISD-UHFFFAOYSA-N 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000002537 cosmetic Substances 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 238000011321 prophylaxis Methods 0.000 title abstract 2
- 230000037307 sensitive skin Effects 0.000 title abstract 2
- 238000011282 treatment Methods 0.000 title abstract 2
- 230000002757 inflammatory effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/008—Preparations for oily skin
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cosmetics (AREA)
Abstract
NOVOS DERIVADOS DE ISOBUTIRAMIDA, PREPARAÇÕES COSMÉTICAS E/OU DERMATOLÓGICAS CONTENDO TAIS COMPOSTOS, ASSIM COMO SEU USO PARA A PROFILAXIA CONTRA E TRATAMENTO DE PELE SENSÍVEL, EM PARTICULAR, INFLAMADA OU DE CONDIÇÕES INFLAMATÓRIOS DA PELE. A presente invenção refere-se a novas isobutiramidas.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102020210535.9A DE102020210535A1 (de) | 2020-08-19 | 2020-08-19 | Neue Isobutyramidderivate, kosmetische und/oder dermatologischen Zubereitungen, solche Verbindungen enthaltend, sowie deren Verwendung zur Prophylaxe vor und Behandlung von sensibler, insbesondere entzündeter Haut bzw. entzündlichen Hautzuständen |
| PCT/EP2021/071523 WO2022037927A1 (de) | 2020-08-19 | 2021-08-02 | Neue isobutyramidderivate, kosmetische und/oder dermatologischen zubereitungen, solche verbindungen enthaltend, sowie deren verwendung zur prophylaxe vor und behandlung von sensibler, insbesondere entzündeter haut bzw. entzündlichen hautzuständen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112023003093A2 true BR112023003093A2 (pt) | 2023-03-28 |
Family
ID=77543471
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112023003093A BR112023003093A2 (pt) | 2020-08-19 | 2021-08-02 | Novos derivados de isobutiramida, preparações cosméticas e/ou dermatológicas contendo tais compostos, assim como seu uso para a profilaxia contra e tratamento de pele sensível, em particular, inflamada ou de condições in-flamatórios da pele |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230312495A1 (pt) |
| EP (1) | EP4200285A1 (pt) |
| CN (1) | CN116096346A (pt) |
| BR (1) | BR112023003093A2 (pt) |
| DE (1) | DE102020210535A1 (pt) |
| WO (1) | WO2022037927A1 (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116554122B (zh) * | 2023-06-29 | 2023-09-19 | 南京桦冠生物技术有限公司 | α-酮酸酰胺或取代草酸酰胺酯类化合物及其组合物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102011083259A1 (de) | 2011-09-23 | 2013-03-28 | Beiersdorf Ag | Alkylamidothiazole, deren kosmetische oder dermatologische Verwendung sowie kosmetische oder dermatologische Zubereitungen mit einem Gehalt an solchen Alkylamidothiazolen |
| DE102013226711A1 (de) | 2013-12-19 | 2015-06-25 | Beiersdorf Ag | Verwendung von Alkylamidothiazolen in kosmetischen oder dermatologischen Zubereitungen zur Prophylaxe vor und Behandlung von sensibler Haut |
-
2020
- 2020-08-19 DE DE102020210535.9A patent/DE102020210535A1/de not_active Withdrawn
-
2021
- 2021-08-02 BR BR112023003093A patent/BR112023003093A2/pt unknown
- 2021-08-02 EP EP21762623.3A patent/EP4200285A1/de active Pending
- 2021-08-02 CN CN202180055944.7A patent/CN116096346A/zh active Pending
- 2021-08-02 US US18/041,742 patent/US20230312495A1/en active Pending
- 2021-08-02 WO PCT/EP2021/071523 patent/WO2022037927A1/de unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE102020210535A1 (de) | 2022-03-24 |
| US20230312495A1 (en) | 2023-10-05 |
| CN116096346A (zh) | 2023-05-09 |
| WO2022037927A1 (de) | 2022-02-24 |
| EP4200285A1 (de) | 2023-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Carrasco et al. | Photoactivation of ROS production in situ transiently activates cell proliferation in mouse skin and in the hair follicle stem cell niche promoting hair growth and wound healing | |
| CA3006294A1 (en) | Combinations of rapamycin and metformin for the treatment of joint and skin diseases | |
| BR112018000953A2 (pt) | produto de proteína adesiva de mexilhão e aplicações do mesmo na supressão de inflamações de pele | |
| BR112018002547A2 (pt) | benzimidazóis substituídos, sua preparação e seu uso como produtos farmacêuticos | |
| Osmola-Mankowska et al. | The sun–our friend or foe? | |
| BR112022011917A2 (pt) | Fluoroalquil-oxadiazois e seus usos | |
| BR112023003093A2 (pt) | Novos derivados de isobutiramida, preparações cosméticas e/ou dermatológicas contendo tais compostos, assim como seu uso para a profilaxia contra e tratamento de pele sensível, em particular, inflamada ou de condições in-flamatórios da pele | |
| BR112014006455A2 (pt) | alquilamidotiazóis, preparações cosméticas ou dermatológicas com um teor de um ou vários alquilamidotiazóis e uso de um ou vários alquilamidotiazóis | |
| BR112021016296A2 (pt) | Formulações tópicas de rapamicina e seu uso em tratamento de angiofibromas faciais e outros distúrbios de pele | |
| BR112022000251A2 (pt) | Derivados macrocíclicos de espirociclo como inibidores de mcl-1 | |
| BR112016000335A8 (pt) | método de tratamento da rosácea papulopustular, de tratamento de lesões inflamatórias da rosácea papulopustular e uso de uma composição farmacêutica | |
| BR112023000212A2 (pt) | Éter macrocíclico contendo derivados de indol como inibidores de mcl-1 | |
| BR112021016833A2 (pt) | Compostos com atividade indutora de ferroptose e métodos de seu uso | |
| BR112020024412A8 (pt) | Anticorpos, composição farmacêutica, kit, ácido nucleico, célula hospedeira, métodos de tratamento ou prevenção de câncer, de redução da atividade, de aumento da atividade e de aumento da ativação | |
| ES2862198T3 (es) | Cosmético para aclarar la piel | |
| MX2016007760A (es) | Uso de alquilamidotiazoles en preparaciones cosmeticas o dermatologicas para la profilaxis y el tratamiento de piel sensible. | |
| BR112021025732A2 (pt) | Inibidores macrocíclicos de mcl-1 | |
| BR112018012749A2 (pt) | composições para higiene pessoal | |
| Nisar et al. | Eriodictyol protects skin cells from UVA irradiation-induced photodamage by inhibition of the MAPK signaling pathway | |
| BR112021017957A2 (pt) | Derivado tienoeterocíclico, método de preparação do mesmo e uso médico do mesmo | |
| BR112021020356A2 (pt) | Composição cosmética tópica e usos da mesma | |
| BR102018006449A8 (pt) | Composições tópicas compreendendo retinoides e agentes de limpeza poliméricos de baixa irritação | |
| Liu et al. | Preventive effect of Diallyl Trisulfide on cutaneous toxicities induced by EGFR inhibitor | |
| BR112018074543A2 (pt) | composição de despigmentação, uso da composição de despigmentação, método para prevenir e/ou reduzir a pigmentação e método para prevenir e/ou reduzir os distúrbios da pigmentação da pele | |
| BR112022009142A2 (pt) | Derivados de indol macrocíclicos como inibidores de mcl-1 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25G | Requested change of headquarter approved |
Owner name: BEIERSDORF AG (DE) |